Mental health of individuals with pre-existing mental illnesses at the beginning of the COVID-19 pandemic: results of the German National Cohort (NAKO).


Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2024
Historique:
received: 19 06 2024
accepted: 03 09 2024
medline: 8 10 2024
pubmed: 8 10 2024
entrez: 8 10 2024
Statut: epublish

Résumé

The COVID-19 pandemic prompted a range of studies on mental health, with mixed results. While numerous studies reported worsened conditions in individuals with pre-existing mental disorders, others showed resilience and stability in mental health. However, longitudinal data focusing on the German population are sparse, especially regarding effects of age and pre-existing mental disorders during the early stages of the pandemic. To assess the interplay between psychiatric history, age, and the timing of the pandemic, with a focus on understanding how these factors relate to the severity of depression and anxiety symptoms. Exploratory analyses were based on 135,445 individuals aged 20-72 years from the German National Cohort (NAKO). Depressive and anxiety symptoms were assessed before and after the first wave of the pandemic. Inferential statistical analyses and negative binomial regression models were calculated. Persons with a self-reported psychiatric history exhibited comparable levels of depression and anxiety symptom severity after the first wave of the pandemic compared to the time before. In contrast, individuals without a psychiatric history, particularly those in their 20s to 40s, experienced an increase in mental health symptom severity during the first wave of the pandemic. Analyses focuses on the first wave of the pandemic, leaving the long-term mental health effects unexplored. Future research should consider age-specific and mental-health-related factors when addressing global health crises. Additionally, it is important to explore factors influencing resilience and adaptation, aiming to develop targeted interventions and informed policies for effective mental health management during pandemics.

Sections du résumé

Background UNASSIGNED
The COVID-19 pandemic prompted a range of studies on mental health, with mixed results. While numerous studies reported worsened conditions in individuals with pre-existing mental disorders, others showed resilience and stability in mental health. However, longitudinal data focusing on the German population are sparse, especially regarding effects of age and pre-existing mental disorders during the early stages of the pandemic.
Objectives UNASSIGNED
To assess the interplay between psychiatric history, age, and the timing of the pandemic, with a focus on understanding how these factors relate to the severity of depression and anxiety symptoms.
Methods UNASSIGNED
Exploratory analyses were based on 135,445 individuals aged 20-72 years from the German National Cohort (NAKO). Depressive and anxiety symptoms were assessed before and after the first wave of the pandemic. Inferential statistical analyses and negative binomial regression models were calculated.
Results UNASSIGNED
Persons with a self-reported psychiatric history exhibited comparable levels of depression and anxiety symptom severity after the first wave of the pandemic compared to the time before. In contrast, individuals without a psychiatric history, particularly those in their 20s to 40s, experienced an increase in mental health symptom severity during the first wave of the pandemic.
Limitations UNASSIGNED
Analyses focuses on the first wave of the pandemic, leaving the long-term mental health effects unexplored.
Conclusion UNASSIGNED
Future research should consider age-specific and mental-health-related factors when addressing global health crises. Additionally, it is important to explore factors influencing resilience and adaptation, aiming to develop targeted interventions and informed policies for effective mental health management during pandemics.

Identifiants

pubmed: 39377001
doi: 10.3389/fpubh.2024.1451631
pmc: PMC11456423
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1451631

Informations de copyright

Copyright © 2024 Stein, Pabst, Berger, Karch, Teismann, Streit, Grabe, Mikolajczyk, Massag, Lieb, Castell, Heise, Schulze, Gastell, Harth, Obi, Peters, Huemer, Bohmann, Leitzmann, Schipf, Meinke-Franze, Hebestreit, Fuhr, Michels, Jaskulski, Stocker, Koch-Gallenkamp, Willich, Keil, Löffler, Wirkner and Riedel-Heller.

Déclaration de conflit d'intérêts

HG has received travel grants and speakers honoraria from Fresenius Medical Care, Neuraxpharm, Servier and Janssen Cilag as well as research funding from Fresenius Medical Care. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Auteurs

Janine Stein (J)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), University of Leipzig, Leipzig, Germany.

Alexander Pabst (A)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), University of Leipzig, Leipzig, Germany.

Klaus Berger (K)

Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.

André Karch (A)

Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.

Henning Teismann (H)

Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.

Fabian Streit (F)

Department of Genetic Epidemiology in Psychiatry, Medical Faculty Mannheim, Central Institute of Mental Health, University of Heidelberg, Heidelberg, Germany.

Hans J Grabe (HJ)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.

Rafael Mikolajczyk (R)

Interdisciplinary Centre for Health Sciences, Institute for Medical Epidemiology, Biometrics and Informatics (IMEBI), Medical Faculty of the Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.
German Center for Mental Health (DZPG), partner site Halle-Jena-Magdeburg, Magdeburg, Germany.

Janka Massag (J)

Interdisciplinary Centre for Health Sciences, Institute for Medical Epidemiology, Biometrics and Informatics (IMEBI), Medical Faculty of the Martin Luther University Halle-Wittenberg, Halle (Saale), Germany.

Wolfgang Lieb (W)

Institute of Epidemiology, Faculty of Medicine, Kiel University, Kiel, Germany.

Stefanie Castell (S)

Department of Epidemiology, Helmholtz Centre for Infection Research, Brunswick, Germany.

Jana-Kristin Heise (JK)

Department of Epidemiology, Helmholtz Centre for Infection Research, Brunswick, Germany.

Matthias B Schulze (MB)

Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany.

Sylvia Gastell (S)

NAKO Study Center, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.

Volker Harth (V)

Institute of Occupational and Maritime Medicine (ZfAM), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Nadia Obi (N)

Institute of Occupational and Maritime Medicine (ZfAM), University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Annette Peters (A)

Institute of Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Neuherberg, Germany.
Chair of Epidemiology, Medical Faculty, Institute for Medical Information Processing, Biometry and Epidemiology, Ludwig-Maximilians-Universität München, Munich, Germany.
German Center for Mental Health (DZPG), partner site München-Augsburg, Augsburg, Germany.

Marie-Theres Huemer (MT)

Institute of Epidemiology, Helmholtz Zentrum München - German Research Center for Environmental Health (GmbH), Neuherberg, Germany.

Patricia Bohmann (P)

Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.

Michael Leitzmann (M)

Department of Epidemiology and Preventive Medicine, University of Regensburg, Regensburg, Germany.

Sabine Schipf (S)

Institute for Community Medicine, Department SHIP/Clinical-Epidemiological Research, University Medicine Greifswald, Greifswald, Germany.

Claudia Meinke-Franze (C)

Institute for Community Medicine, Department SHIP/Clinical-Epidemiological Research, University Medicine Greifswald, Greifswald, Germany.

Antje Hebestreit (A)

Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.

Daniela C Fuhr (DC)

Leibniz Institute for Prevention Research and Epidemiology - BIPS, Bremen, Germany.
Health Sciences, University of Bremen, Bremen, Germany.

Karin B Michels (KB)

Faculty of Medicine and Medical Center, Institute for Prevention and Cancer Epidemiology, University of Freiburg, Freiburg, Germany.

Stefanie Jaskulski (S)

Faculty of Medicine and Medical Center, Institute for Prevention and Cancer Epidemiology, University of Freiburg, Freiburg, Germany.

Hannah Stocker (H)

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Lena Koch-Gallenkamp (L)

Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Stefan N Willich (SN)

Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.

Thomas Keil (T)

Institute of Social Medicine, Epidemiology and Health Economics, Charité - Universitätsmedizin Berlin, Berlin, Germany.
Institute of Clinical Epidemiology and Biometry, University of Würzburg, Würzburg, Germany.
State Institute of Health I, Bavarian Health and Food Safety Authority, Erlangen, Germany.

Markus Löffler (M)

Institute for Medical Informatics, Statistics, and Epidemiology, University of Leipzig, Leipzig, Germany.

Kerstin Wirkner (K)

Leipzig Research Center for Civilization Diseases LIFE, Medical Faculty, University of Leipzig, Leipzig, Germany.

Steffi G Riedel-Heller (SG)

Institute of Social Medicine, Occupational Health and Public Health (ISAP), University of Leipzig, Leipzig, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH